2020
DOI: 10.1021/acschemneuro.0c00475
|View full text |Cite
|
Sign up to set email alerts
|

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induced Parkinson’s Disease in Mouse: Potential Association between Neurotransmitter Disturbance and Gut Microbiota Dysbiosis

Abstract: Recent studies have revealed significant roles of neurotransmitters and gut microbiota along the gut−brain axis in Parkinson's disease (PD); however, the potential mechanisms remain poorly understood. In the current study, 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced characteristic PD neurobehavior changes accompanied by increased α-synuclein, apoptotic protein Bim, and cleaved caspase-3 and decreased expression of tyrosine hydroxylase (TH). Meanwhile, the tryptophan (Trp) and tyrosine (Tyr) neur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
18
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(19 citation statements)
references
References 35 publications
1
18
0
Order By: Relevance
“…Actinobacteria Bifidobacteriaceae Coriobacteriaceae Decreased in IBS (247,248) Decreased in IBD (249,250) Decreased in UC and CD (251) Increased in IBS (248) Decreased in IBD (249) Increased in UC and CD (252) Increased in Parkinson's disease (253)(254)(255) Decreased in Alzheimer's disease (251) Decreased in autism spectrum disorder (256,257) Increased in bipolar disorder (258) Decreased in Parkinson's disease (259) Increased in bipolar disorder (258) Increases TPH1 and decreases SERT expression (260) Increases 5-HT in CNS (261) Increases mucosal 5-HT, and expression of SERT; 5-HTR 2 and 5-HTR 4 (237) Bifidobacterium are decreased in SERT -/mouse (262) Correlated with increased levels of serotonin (263) Microbial manipulation: prebiotic and probiotics in GI disorders (264)(265)(266) Probiotic supplementations in neurodegenerative disorders (267,268);…”
Section: -Ht Alterations Therapeutic Approachmentioning
confidence: 99%
“…Actinobacteria Bifidobacteriaceae Coriobacteriaceae Decreased in IBS (247,248) Decreased in IBD (249,250) Decreased in UC and CD (251) Increased in IBS (248) Decreased in IBD (249) Increased in UC and CD (252) Increased in Parkinson's disease (253)(254)(255) Decreased in Alzheimer's disease (251) Decreased in autism spectrum disorder (256,257) Increased in bipolar disorder (258) Decreased in Parkinson's disease (259) Increased in bipolar disorder (258) Increases TPH1 and decreases SERT expression (260) Increases 5-HT in CNS (261) Increases mucosal 5-HT, and expression of SERT; 5-HTR 2 and 5-HTR 4 (237) Bifidobacterium are decreased in SERT -/mouse (262) Correlated with increased levels of serotonin (263) Microbial manipulation: prebiotic and probiotics in GI disorders (264)(265)(266) Probiotic supplementations in neurodegenerative disorders (267,268);…”
Section: -Ht Alterations Therapeutic Approachmentioning
confidence: 99%
“…An optimized intestinal microecological environment was more likely to perform neurotransmitter synthesis and other functions more effectively [44]. Tyr was also a precursor of neurotransmitters formation, and the increase of Tyr can increase the level of neurotransmitter in the body [45]. The supplementation of OTP can increase the level of Gln and Tyr.…”
Section: Discussionmentioning
confidence: 99%
“…Studies have shown that reduced Coriobacteriaceae abundance is linked to T2DM [ 29 ] and Parkinson’s disease [ 30 ]. Probiotic and prebiotic treatments have been shown to increase the relative abundance of Coriobacteriaceae [ 31 , 32 ].…”
Section: Discussionmentioning
confidence: 99%